Cambridge BioMarketing: Rare disease agency Cambridge Bio goes global with $35M buyout by Irish UDG

Rare disease agency Cambridge BioMarketing has been snapped up by Ireland-based healthcare service provider UDG Healthcare for $35 million. A specialist in rare disease and orphan drug launches, the Cambridge-based agency is part of UDG's plans for U.S. expansion.